Edit |   |
---|---|
Antigenic Specificity | VEGF Receptor 2 |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | FC, IHC, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human VEGF Receptor 2 Recombinant Antibody (Ramucirumab). Recombinant monoclonal antibody to VEGF Receptor 2. Ramucirumab (IMC-1121B) is a fully human monoclonal antibody (IgG1) for the treatment of solid tumors. It is directed against the vascular endothelial growth factor receptor 2 (VEGFR2). By binding to VEGFR2 it works as a receptor antagonist blocking the binding of vascular endothelial growth factor (VEGF) to VEGFR2. VEGFR2 is known to mediate the majority of the downstream effects of VEGF in angiogenesis. |
Immunogen | The details of the immunogen for this antibody are not available. |
Other Names | Ramucirumab;Cyramza;947687-13-0;IMC-1121B;LY3009806;IMC-1121B;Cyramza;KDR;kinase insert domain receptor (a type III receptor tyrosine kinase);vascular endothelial growth factor receptor 2;CD309;FLK1;VEGFR;VEGFR2;soluble VEGFR2;fetal liver kinase 1;fetal l |
Gene, Accession # | UniProt: P35968 |
Catalog # | TAB-079 |
Price | please inquire |
Order / More Info | VEGF Receptor 2 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |